Investigational Alzheimer's drug improves biomarkers of the disease
              by Washington University School of MedicineRandall Bateman, MD, director of the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), an ongoing international clinical trial to evaluate e          
          
              
              Updated on: April 16,2024
              
              
                   11
                  11              
              
              
          
       11
                  11              
              
              
          Investigational Alzheimer's drug improves biomarkers of the disease
              by Washington University School of MedicineRandall Bateman, MD, director of the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), an ongoing international clinical trial to evaluate e          
          
              
              Updated on:April 16,2024
              
              
                   11
                  11              
              
              
          
       11
                  11              
              
              
           
					
































 
						





 
					 
				 
      



